Cancer is one of the leading causes of death worldwide.
According to WHO, by 2050, there will be 35 million new
cases annually and 18 million related deaths annually.
We offer a cutting edge approach joining the forces of
Nanotechnology and Cellular Therapies to beat solid tumor Cancer.
Company Details
- Employees
- 2
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Odycell Nanotherapies Questions
Odycell Nanotherapies's LinkedIn profile is https://www.linkedin.com/company/odycell-nanotherapies
Odycell Nanotherapies has
2 employees.
View email and phone details for 2
employees at Odycell Nanotherapies.
Odycell Nanotherapies's industry is
Biotechnology Research
Odycell Nanotherapies's top competitors are
Levar Biotech,
Endeavor Argentina,
Circa Therapeutics,
Vitropollen,
Agrosintex,
Ab Astra Inc.,
Securitas Biosciences,
Oncoliq,
Abydos Bioscience,
Cites.
Odycell Nanotherapies's categories are Biotechnology Research
